LITTLE FALLS, N.J., Sept. 1, 2016 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMN) is pleased to announce that Seth M. Yellin has recently been promoted to Executive Vice President, Strategy and Corporate Development from Senior Vice President, Corporate Development. In his new role, Mr. Yellin will have responsibility for Cantel’s strategic planning function along with his current role of corporate development, which includes leading the Company’s active acquisition program.
Jorgen Hansen, Cantel’s President and Chief Executive Officer stated, “Seth is the ideal candidate to lead the expanded strategic planning function for Cantel. He’s played an integral role in the development of our past two five-year strategic plans and this responsibility goes hand-in-hand with his excellent leadership of our acquisition program.”
Mr. Yellin joined Cantel Medical in April, 2012 as Vice President, Corporate Development. He received a BA from Princeton University and an MBA from The Wharton School at the University of Pennsylvania.
About Cantel Medical
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel’s filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cantel-medical-promotes-seth-m-yellin-to-executive-vice-president-300321345.html
SOURCE Cantel Medical Corp.
